Mylan CEO Heather Bresch testifies earlier this year on Capitol Hill about the EpiPen. Mylan has drawn criticism over the price of the allergy injection. Photo: Pablo Martinez Monsivais, STF / Copyright 2016 The Associated Press. All rights reserved.
{}